Rapid UTI PCR testing entered UK clinical use for the first time at the Royal Hospital Chelsea on October 28, 2026.

Genefluence’s rapid PCR test for UTIs is now in clinical use, enabling one-hour detection of pathogens and resistance genes.

Labcorp data presented at IDWeek 2026 show measles PCR testing nearly quadrupled and positivity rose sharply from April 2025 ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the ...

Co-Diagnostics (Salt Lake City, UT) is bringing PCR mosquito testing for infectious disease directly into mosquito abatement districts, aiming to help public-health teams identify infected mosquito ...

A retrospective study of 112 low-risk living-donor kidney transplant recipients found that CMV DNAemia was associated with ...

Medical and consumer genetics innovator Genefluence today announces the first use of its rapid, near-patient diagnostic platform to screen ...

A retrospective study of 368 peritoneal dialysis patients identified diabetes, elevated C-reactive protein, and high ...

Capitalize on preventive care demand through at-home testing, whole-genome sequencing and AI-powered interpretation, with North America leading adoption.Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "DNA ...

Transformative Biotech, LLC (T-Bio), a molecular diagnostics company focused on direct-to-PCR testing, announced it has been ...

Co-Diagnostics Inc. CODX said on Tuesday that it moved closer to launching its point-of-care tuberculosis testing technology ...

Asia PET Series in Jakarta gathers recycling players to examine ASEAN’s evolving EPR requirements, recycled plastics markets and EU packaging compliance. JAKARTA, INDONESIA, October 28, 2026 ...